Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

OrbiMed

OrbiMed
VC INVESTOR TYPE
Active STATUS
43 PROFESSIONALS
492 INVESTMENTS
150 PORTFOLIO
214 EXITS
Description

OrbiMed is an investment firm that seeks to invest in the pharmaceutical, life science, digital health, healthcare service, medical device, biopharmaceutical, diagnostic, healthcare technology and biotechnology sectors. It was founded in 1989 and is headquartered in New York, New York.

Website
Investor Status
Actively Seeking New Investments
Year Founded
1989
Primary Investor Type
Venture Capital
Other Investor Types
Asset Manager
Growth/Expansion
Primary Office
  • 601 Lexington Avenue (at 53rd Street)
  • 54th Floor
  • New York, NY 10022
  • United States

+1 (212) 000-0000

OrbiMed Investments & Acquisitions (492)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Arcutis 23-Apr-2019 Early Stage VC 0000 Biotechnology Clinical Trials - Phase 2 00000000 00000000000 00
00000000000 000000 29-Mar-2019 00000 00000 00000 Drug Discovery Clinical Trials - General 0000 000000 00.0
0000000 0000000000 27-Mar-2019 00000 00000 0000 Biotechnology Generating Revenue 0000 000000 00.0
000000 00000000000 25-Mar-2019 00000 00000 00000 Drug Discovery Clinical Trials - Phase 1 0000 000000
00000 18-Mar-2019 00000 00000 0000 Biotechnology Clinical Trials - Phase 2 00000 000000 00
00000000000 12-Mar-2019 00000 00000 0000 Biotechnology Clinical Trials - Phase 2
00000 20-Feb-2019 00000 00000 0000 Drug Discovery Pre-Clinical Trials 0000 000000000
0000000 0000000000 20-Feb-2019 00000 00000 00000 Pharmaceuticals Clinical Trials - Phase 2
Passage Bio 14-Feb-2019 Early Stage VC 00000 Other Healthcare Services Generating Revenue 0000 000000 00.0
Health Catalyst 06-Feb-2019 Later Stage VC 00000 Enterprise Systems (Healthcare) Generating Revenue
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore OrbiMed’s full profile, request a free trial.

OrbiMed Exits (210)

Company Name Exit Date Exit Type Exit Size Status Buyers
NextCure 09-May-2019 IPO 0000 Completed
00000000000 02-May-2019 000 0000 Completed
000000000 00000000 18-Apr-2019 000000000000000000 00.000 Completed
  • 00000 00000
0000000 00000 0000 17-Apr-2019 000 00000 Completed
0000000 13-Mar-2019 000000000000000000 Completed
  • 00 000000000000000
0000000 0000000 26-Feb-2019 000000000000000000 000 Completed
  • 000000000 0000000
000000 00000000000 18-Feb-2019 0000000000: 000000 Completed
000000 14-Feb-2019 000 0000 Completed
  • 00000000000 000000
Harpoon Therapeutics 11-Feb-2019 IPO 0000 Completed
Alector 07-Feb-2019 IPO 00000 Completed
To view this investor’s complete exits history, request access »

OrbiMed Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is reserved for PitchBook Platform accredited users. To explore OrbiMed‘s full profile, request access.

Request full access to PitchBook

OrbiMed Team (107)

Name Title Deals Funds Boards Office Contact
Info
Evan Sotiriou Chief Financial Officer New York, NY
Daniel Rhee Chief Technology Officer New York, NY
David Wang MD Partner & Senior Managing Director 0 0 0 Shanghai, China
Sunny Sharma Partner & Senior Managing Director 0 0 0 Mumbai, India
Jonathan Wang Ph.D Partner, Senior Managing Director & Co-Founder of the Asia Fund 00 0 0 Shanghai, China

35 Former Team Members

You’re viewing 5 of 107 team members. Get the full list »

OrbiMed Co-Investors (373)

Name With Exits Lead Partner
RA Capital Management 12 0 00
Deerfield Management 00 0 0
Lilly Asia Ventures 00 0
Rock Springs Capital 0 0 0
Vivo Capital 0 0 0
To view this investor’s complete co-investor history, request access »